Bilateral Lacrimal Gland Masses: Unusual Case of Metastatic Renal Cell Carcinoma

Sabatini, Peter; Ducic, Yadranko
February 2009
Journal of Otolaryngology -- Head & Neck Surgery;Feb2009, Vol. 38 Issue 1, pE1
Academic Journal
Case Study
A case report on the unusual occurrence of metastatic renal cell carcinoma (RCC) in bilateral lacrimal glands is presented. The 61-year-old patient is a Panamanian woman with lesions on her eyelids and the right side of her neck. Her medical history notes a right nephrectomy and resections of RCC metastases. Brief statistics are given concerning the presentation of clear cell carcinomas and the common sites of metastasis.


Related Articles

  • Hepatocellular carcinoma metastasis to the lacrimal gland: A case report. HUA CHEN; JINPENG LI; LIJUN WANG; NING CONG; CONGCONG SHI; JINLONG SONG; WENZHE BU // Oncology Letters;2014, Vol. 8 Issue 2, p911 

    Hepatocellular carcinoma (HCC) is a globally common neoplasm, with regional metastasis associated with >50% of the tumors. Extrahepatic metastasis is also common, with the lungs, diaphragm, abdominal lymph nodes and bone being the most frequently affected regions. However, to the best of our...

  • Targeted therapy for metastatic renal cell cancer in older patients.  // British Journal of Hospital Medicine (17508460);Apr2011, Vol. 72 Issue 4, p190 

    The article discusses a study by H. Khambati, T.K. Choueiri, C.K. Kollmannsberger and colleagues to examine the efficacy of targeted therapy for metastatic renal cell carcinoma in older population. The data analysis of patients treated with first-line antivascular endothelial growth factor...

  • Metastatic Renal Cell Carcinoma: An Unusual Cause of Bleeding Pancreatic Mass. GAJENDRA, SMEETA; SACHDEV, RITESH; MOHAPATRA, ISHANI; GOEL, RUCHIKA; GOEL, SHALINI // Journal of Clinical & Diagnostic Research;Sep2015, Vol. 9 Issue 9, p15 

    Renal Cell Carcinoma metastasizing to pancreas is uncommon, occurring in 1-2% of cases; lung being the most common site. It is usually asymptomatic, or may present as abdominal pain, weight loss, pancreatitis or gastrointestinal bleeding. Herein, we present a case of 75-year-old male presented...

  • Unusually Large Cutaneous Metastases of Renal Cell Carcinoma. Peris, K.; Fargnoli, M. C.; Lunghi, F.; Chimenti, S. // Acta Dermato-Venereologica;Jan/Feb2001, Vol. 81 Issue 1, p77 

    Describes a young man with a history of renal cell carcinoma (RCC) who presented with cutaneous metastases of unusually large size with a rapid and fatal clinical course. Presence of red-purplish masses; Consistency with the diagnosis of cutaneous metastases or renal cell adenocarcinoma;...

  • Bbrek hcreli kanserde "omental cake" oluÅŸumu: Olgu sunumu ve literatrn gzden geirilmesi. Kuzgunbay, Barış; Gören, Mehmet Reşit; Güvel, Sezgin // Turkish Journal of Urology;Jun2011, Vol. 37 Issue 2, p180 

    Peritoneal and omental metastasis are rare types of metastasis for renal cell carcinoma (RCC). In this report, we present a 72-year old women with omental cake formation due to omentum metastasis of RCC and review the literature.

  • Renal Cell Carcinoma with Unusual Skeletal Metastasis to Tibia and Ankle: A Case Report and Review of Literature. SHANKAR, KIRAN; KUMAR, DURGESH; KUMAR, KARIYANAKATTE VEERAIAH VEERENDRA; PREMLATA, CHENNAGIRI // Journal of Clinical & Diagnostic Research;Nov2016, Vol. 10 Issue 11, p1 

    Renal Cell Carcinoma (RCC) accounts for 5% of the epithelial malignancies worldwide with clear cell carcinoma accounting for 85% of these malignancies. One third of these patients experience synchronous metastatic disease and 20-30% of the remaining patients experience metachronous metastatic...

  • Renal cell carcinoma bone metastasis—elucidating the molecular targets. Kristy Weber; Michele Doucet; Scott Kominsky // Cancer & Metastasis Reviews;Dec2007, Vol. 26 Issue 3/4, p691 

    Abstract  The development of bone metastasis from renal cell carcinoma (RCC) signals a transition to a terminal state for the patient with previously isolated disease. These patients may suffer the morbidity of severe, persistent pain, pathologic fractures, and spinal compression...

  • Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma—data from the Czech registry. Buchler, T.; Klapka, R.; Melichar, B.; Brabec, P.; Dušek, L.; Vyzula, R.; Abrahamova, J. // Annals of Oncology;Feb2012, Vol. 23 Issue 2, p395 

    Background: Sequential therapy with tyrosine kinase inhibitors (TKIs), sunitinib and sorafenib, is a common treatment choice for patients with advanced/metastatic renal cell carcinoma (mRCC) despite lack of randomised trials. The aim of this retrospective registry-based study was to analyse the...

  • WS3–3FIRST EXPERIENCE OF ACTIVE SURVEILLANCE PRIOR TO SYSTEMIC TARGET THERAPY IN PATIENTS WITH METASTATIC RENAL CELL CANCER. Matsubara, N.; Mukai, H.; Naito, Y.; Ito, K.; Komai, Y.; Sakai, Y. // Annals of Oncology;Nov2013 Supplement 9, Vol. 24, pix28 

    No abstract available.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics